STAT3 and lung cancer: reported that the inhibition of ATM has the potential to achieve the reversal of epithelial‐mesenchymal transition (EMT) and the reduction in metastatic ability of cisplatin‐resistant lung cancer cells, which operates via the JAK/STAT3/PD‐L1 pathway.